The signs of hemorrhages, edema, and tissue damage were absent in the test group (Shabbir et al., 2022)
C.KeatingS.WuP.SimonJ
Farxiga is approved for non-diabetic patients with heart failure or chronic kidney disease, but not specifically for weight loss
Two safety principles matter most: Don't use supplements to cover up red-flag symptoms Don't add multiple new variables when your body is still adjusting to a GLP-1 When To Ask Your Clinician: Persistent Vomiting, Severe Pain, Reflux, Or Rapid Weight Loss Check in with your prescribing clinician promptly if you have: Persistent vomiting or inability to keep fluids down Severe or worsening abdominal pain Significant reflux symptoms (burning, regurgitation) that are escalating Signs of dehydration (dizziness, very dark urine, weakness) Rapid weight loss that feels out of proportion to your intake GLP-1 medications can be associated with GI adverse effects, and in some cases more serious issues need to be ruled out
The clinician must review the specific medications, dosing, treatment response, side effects, and relevant health conditions
Dietary counseling
